Green Life Science Corrects Sale Contract Disclosure Confirming Global Partner UPL Limited with 10.2 Billion KRW Brazil Export Deal

The correction lifts the disclosure reservation on the counterparty, revealing UPL Limited as the buyer for the 10.2 billion KRW plant protection chemicals contract.
The contract amount represents 41.18% of 2024 sales, targeting the Brazilian market with a top-tier global agricultural chemicals firm.
Since the correction only adds counterparty details without modifying the original contract terms or financial figures, the fundamental impact on shareholder value is neutral.
[AI Summary]Green Life Science’s correction merely discloses the previously withheld counterparty UPL Limited for an existing contract, with no change in financials, capital structure, or dilution risk; the announcement is neutral for valuation.